Loading organizations...
§ Venture Capital · Seattle, WA, USA
Venture capital firm investing in early-stage healthcare and biotech startups, co-investing in health technology funding rounds.
HCX Ventures is a venture capital firm that invests in early-stage startups, primarily focusing on the healthcare and biotech sectors. The firm actively participates as a co-investor in funding rounds, aiming to support innovative companies developing advanced health technologies and solutions. HCX Ventures seeks to identify and back promising ventures that are poised to disrupt the medical landscape through novel diagnostics, therapeutics, and digital health platforms. Their investment thesis centers on companies addressing critical unmet needs and demonstrating strong scientific foundations within the complex healthcare ecosystem. In a notable investment, HCX Ventures co-invested in Endpoint Health's $52.0 million Series A round on June 1, 2022. This significant funding round also saw participation from other prominent investors, including Adjuvant Capital and Anzu Partners, highlighting a collaborative approach to financing high-potential companies in critical health areas.
HCX Ventures has 1 tracked investment across 1 company. The latest tracked deal is $52.0M Series A in Endpoint Health in June 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 1, 2022 | Endpoint Health | $52.0M Series A | — | Adjuvant Capital, Anzu Partners, BoxOne Ventures, Domain Associates, Vensana Capital, Alix Ventures, AME Cloud Ventures, Boom Capital, Charlie Petty, Humboldt Fund, Mayfield, The Venture Collective, Wireframe Ventures, Yaya Capital |